These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 25127703)
1. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study. Amrane M; Creuzot-Garcher C; Robert PY; Ismail D; Garrigue JS; Pisella PJ; Baudouin C J Fr Ophtalmol; 2014 Oct; 37(8):589-98. PubMed ID: 25127703 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study. Robert PY; Cochener B; Amrane M; Ismail D; Garrigue JS; Pisella PJ; Baudouin C Eur J Ophthalmol; 2016 Nov; 26(6):546-555. PubMed ID: 27515572 [TBL] [Abstract][Full Text] [Related]
3. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients. Di Pascuale MA; Goto E; Tseng SC Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213 [TBL] [Abstract][Full Text] [Related]
4. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N; Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326 [TBL] [Abstract][Full Text] [Related]
5. Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas. Daull P; Raymond E; Feraille L; Garrigue JS J Ocul Pharmacol Ther; 2018 Dec; 34(10):670-676. PubMed ID: 30312113 [No Abstract] [Full Text] [Related]
6. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study. Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N; Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892 [TBL] [Abstract][Full Text] [Related]
7. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial. Chen M; Gong L; Sun X; Xie H; Zhang Y; Zou L; Qu J; Li Y; He J J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799 [TBL] [Abstract][Full Text] [Related]
8. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Cömez AT; Tufan HA; Kocabıyık O; Gencer B Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565 [TBL] [Abstract][Full Text] [Related]
9. Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients. Oliverio GW; Spinella R; Postorino EI; Inferrera L; Aragona E; Aragona P J Ocul Pharmacol Ther; 2021 Mar; 37(2):90-96. PubMed ID: 33370213 [No Abstract] [Full Text] [Related]
10. One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease. Baudouin C; de la Maza MS; Amrane M; Garrigue JS; Ismail D; Figueiredo FC; Leonardi A Eur J Ophthalmol; 2017 Nov; 27(6):678-685. PubMed ID: 28708219 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness. Scaffidi RC; Korb DR Eye Contact Lens; 2007 Jan; 33(1):38-44. PubMed ID: 17224677 [TBL] [Abstract][Full Text] [Related]
13. A multicenter, double-blind, parallel group, placebo-controlled clinical study to examine the safety and efficacy of T-Clair SPHP700-3 in the management of mild to moderate dry eye in adults. Villani E; Laganovska G; Viola F; Pirondini C; Baumane K; Radecka L; Ratiglia R Cornea; 2011 Mar; 30(3):265-8. PubMed ID: 21099417 [TBL] [Abstract][Full Text] [Related]
14. Lubricant with gelling agent in treating dry eye in adult Chinese patients. Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of topical cyclosporine for the treatment of dry eye disease. Perry HD; Solomon R; Donnenfeld ED; Perry AR; Wittpenn JR; Greenman HE; Savage HE Arch Ophthalmol; 2008 Aug; 126(8):1046-50. PubMed ID: 18695097 [TBL] [Abstract][Full Text] [Related]
16. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. Davitt WF; Bloomenstein M; Christensen M; Martin AE J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478 [TBL] [Abstract][Full Text] [Related]
17. A randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome. McDonald CC; Kaye SB; Figueiredo FC; Macintosh G; Lockett C Eye (Lond); 2002 Sep; 16(5):601-7. PubMed ID: 12194076 [TBL] [Abstract][Full Text] [Related]
19. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Benelli U; Nardi M; Posarelli C; Albert TG Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS; Ji YS; Yoon KC Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]